David Rosa - Biotricity Independent Director
| BTCY Stock | USD 1.39 0.06 4.14% |
Director
Mr. David A. Rosa is Independent Director of the Company since 2016.
| Age | 52 |
| Tenure | 8 years |
| Professional Marks | MBA |
| Phone | (800) 590-4155 |
| Web | https://www.biotricity.com |
David Rosa Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Rosa against Biotricity stock is an integral part of due diligence when investing in Biotricity. David Rosa insider activity provides valuable insight into whether Biotricity is net buyers or sellers over its current business cycle. Note, Biotricity insiders must abide by specific rules, including filing SEC forms every time they buy or sell Biotricity'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Rosa over a year ago Acquisition by David Rosa of 75930 shares of Biotricity subject to Rule 16b-3 |
Biotricity Management Efficiency
The company has return on total asset (ROA) of (0.9517) % which means that it has lost $0.9517 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (41.0079) %, meaning that it created substantial loss on money invested by shareholders. Biotricity's management efficiency ratios could be used to measure how well Biotricity manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| David Kunin | Nortech Systems Incorporated | 54 | |
| David Merrill | PetVivo Holdings | 68 | |
| Laura Philips | Delcath Systems | 56 | |
| Lisa Heine | SurModics | 54 | |
| William Rueckert | Delcath Systems | 64 | |
| Andrew Filler | Biosig Technologies | N/A | |
| Bret Hankey | Bone Biologics Corp | 39 | |
| Ronald Kalich | SurModics | 70 | |
| Samuel Navarro | Biosig Technologies | ||
| Seth Fischer | Biosig Technologies | 61 | |
| William Murray | Nortech Systems Incorporated | N/A | |
| William Coffin | Bone Biologics Corp | 69 | |
| Sherry Grisewood | PetVivo Holdings | N/A | |
| ChihHeng Lu | Ainos Inc | 44 | |
| Jimmy Delshad | Bone Biologics Corp | 74 | |
| David Weild | Biosig Technologies | 59 | |
| Jerome Zeldis | Biosig Technologies | 68 | |
| Manasi Patwardhan | Biosig Technologies | N/A | |
| Julie Stephenson | Biosig Technologies | N/A | |
| Allen Barbieri | Biomerica | 66 | |
| David Dantzker | SurModics | 74 | |
Management Performance
| Return On Equity | -41.01 | ||||
| Return On Asset | -0.95 |
Biotricity Leadership Team
Elected by the shareholders, the Biotricity's board of directors comprises two types of representatives: Biotricity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biotricity. The board's role is to monitor Biotricity's management team and ensure that shareholders' interests are well served. Biotricity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biotricity's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Rosa, Independent Director | ||
| Patricia Kennedy, Director | ||
| George Nikopoulos, Director Development | ||
| Waqaas AlSiddiq, Founder, Chairman, CEO and Executive Officer | ||
| Norman Betts, Independent Director | ||
| Amir Ali, Chief Officer | ||
| John Ayanoglou, Chief Officer | ||
| Andy Wong, Vice Operations | ||
| Matt Zabel, Vice Strategy |
Biotricity Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biotricity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -41.01 | ||||
| Return On Asset | -0.95 | ||||
| Profit Margin | (1.25) % | ||||
| Operating Margin | (0.43) % | ||||
| Current Valuation | 38.1 M | ||||
| Shares Outstanding | 9.31 M | ||||
| Shares Owned By Insiders | 14.81 % | ||||
| Shares Owned By Institutions | 4.70 % | ||||
| Number Of Shares Shorted | 358.44 K | ||||
| Price To Earning | (6.70) X |
Pair Trading with Biotricity
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotricity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotricity will appreciate offsetting losses from the drop in the long position's value.Moving against Biotricity Stock
| 0.6 | NAOV | NanoVibronix | PairCorr |
| 0.58 | HCAT | Health Catalyst Financial Report 14th of May 2024 | PairCorr |
| 0.53 | BBLG | Bone Biologics Corp Financial Report 20th of May 2024 | PairCorr |
| 0.43 | NUWE | Nuwellis Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Biotricity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotricity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotricity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotricity to buy it.
The correlation of Biotricity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotricity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotricity moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotricity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Biotricity Stock analysis
When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is Biotricity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. If investors know Biotricity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biotricity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biotricity is measured differently than its book value, which is the value of Biotricity that is recorded on the company's balance sheet. Investors also form their own opinion of Biotricity's value that differs from its market value or its book value, called intrinsic value, which is Biotricity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotricity's market value can be influenced by many factors that don't directly affect Biotricity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biotricity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotricity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotricity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.